Physician profile

Raj K Narayan

Neurological Surgery · West Islip, NY

NPI 1225060445

$8,267.35

in general payments reported to CMS, 2019-2025

9 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$140.33

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Sirtex Medical INC $4,500.00 2020
Medtronic USA, INC. $3,300.00 2020
Abbott Laboratories $167.54 2021
Boston Scientific Corporation $125.00 2021
Insightec,INC $112.19 2023 Exablate
Lemaitre Vascular, INC. $28.14 2023 Anastoclip Gc 8cm (Medium)
Janssen Pharmaceuticals, INC $23.86 2022
Cardiovascular Systems INC. $10.62 2021

1 company reported research payments only; those appear in the research section below.

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Raj K Narayan

$8,267.35

in general payments reported 2019-2025

Years
2020-2023
Top company
Sirtex Medical INC

https://glasscript.com/doctor/146365/raj-k-narayan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.